Allianz Asset Management
ABVX

Allianz Asset Management’s Abivax ABVX Stock Holding History

Allianz Asset Management’s Portfolio ABVX Stock Details ABVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$423K Sell
3,800
-1,900
-33% -$225K ﹤0.01% 1857
2025
Q4 		$769K Buy
5,700
+2,800
+97% +$306K ﹤0.01% 1766
2025
Q3 		$246K Buy
+2,900
New +$178K ﹤0.01% 1937

Other funds holding ABVX

TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
CP
Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
HI
Helikon Investments London, United Kingdom $2.65B AUM 79.03% 1-Year Est. Return

Allianz Asset Management's ABVX Position: Q1 2026 in Review

Allianz Asset Management reduced its Abivax (ABVX) stake by 33% in Q1 2026, selling an estimated $225K and leaving 3,800 shares worth $423K. The position accounts for ﹤0.01% of the portfolio, ranked #1857.

Allianz Asset Management first reported a position in ABVX in Q3 2025 and has held it in 3 quarters since. The position peaked at $769K in Q4 2025. 254 funds tracked by Wall St. Rank hold ABVX as of Q1 2026.

  • Allianz Asset Management held 3,800 shares of Abivax worth $423K as of Q1 2026.
  • Allianz Asset Management sold 1,900 Abivax shares in Q1 2026, an estimated $225K.
  • Abivax made up ﹤0.01% of Allianz Asset Management's portfolio in Q1 2026, its #1857 holding.
  • Allianz Asset Management first reported a position in Abivax in Q3 2025 and has held it in 3 quarters since.
  • Allianz Asset Management's Abivax position peaked at $769K in Q4 2025.
  • 254 funds tracked by Wall St. Rank held Abivax as of Q1 2026.

Based on Allianz Asset Management's 13F filing for Q1 2026, filed 11 May 2026.